Company: PAVS
Filing Date: 2025-08-04
Form Type: 20-F
Source: 0001929980-25-000590
Chunk: 105

Company: Paranovus Entertainment Technology Ltd.
Filing Date: 2025-08-04
Form: 20-F
Item: Item 5
Chunk 105
---
2024, increased by $2,513,618 or 58.87%. The increase was primarily due to the impairment of goodwill and intangible asset recorded for 2lab3.

Interest income

Our interest income of $156 for the fiscal year ended March 31, 2025 increased by $156 or 100.00%, compared with interest income of $0 for the fiscal year ended March 31, 2024. The interest income was stable during the two years of ended March 31, 2025.

Interest expense

Our interest expense of $261,854 for the fiscal year ended March 31, 2025 increased by $222,687 or 568.56%, compared with interest expense of $39,167 for the fiscal year ended March 31, 2024. The increase was mainly due to the increase of an unsecured loan payable to the related party, bearing a fixed interest rate of 8%.

Other Income

Our other income of $42,612 for the fiscal year ended March 31, 2025 increased by $22,697 or 113.97% compared with other income of $19,915 for the fiscal year ended March 31, 2024. The increase was primarily attribute to the foreign exchange gain of $45,556, offset by non-operating expenses of $2,944 for the fiscal year ended March 31, 2025.

Net loss from continuing operations

Our net loss from continuing operations for the fiscal year ended March 31, 2025 was $7,002,647, representing an increase of $2,713,452 or 63.26%, compared with net loss from continuing operations of $4,289,195 for the fiscal year ended March 31, 2024. The increasing was primarily attribute to the goodwill impairment recorded for 2lab3.

Net loss from discontinued operations

Our net loss from discontinued operations for the fiscal year ended March 31, 2025 was $1,302,782, representing an decrease of $4,335,347, compared with net loss from discontinued operations of $5,638,129 for the fiscal year ended March 31, 2024. This reduction was primarily attributable to the fact that the divested automobile sales business in 2025 accounted for a smaller proportion of our total operations than the discontinued operation nutraceutical and dietary supplements (healthcare products), e-commerce, internet information and advertising business in 2024.

On July 5,